Researchers Discover Enzymes that Impact Effectiveness of Chemotherapy Drug in Treating Pancreatic Cancer

University of Toronto researchers have discovered enzymes that hinder the effectiveness of gemcitabine, a common chemotherapy drug used to treat pancreatic cancer. The study, published in Nature Cancer, sheds light on the mechanisms compromising gemcitabine’s efficacy and offers potential for the development of targeted therapies to improve treatment outcomes for pancreatic cancer patients.